HuffPo: Drumbeats, HIV and Walking Toward the Light

The focus group conversations gripped me. I could not sleep at night, wrestling with the stories of trauma, shame and guilt the men shared. As the stories rattled me and the focus group participants, a new narrative began to unfold: reclaiming an old story of HIV to creating a new horizon of possibility and hope.

HuffPo: Making PrEP Possible for Women

Three-and-a-half years ago, the U.S. Food and Drug Administration approved the HIV treatment drug Truvada as pre-exposure prophylaxis or PrEP for HIV prevention. It was a landmark moment in the decades-long effort to halt HIV transmission. This pill, when taken daily by an HIV-negative person, reduces the likelihood of acquiring HIV by more than 90 percent.

KCBS In Depth: Healing

KCBS? Jane McMillan talks with Dr. Deborah Cohan, obstetrician and gynecologist, who runs the UCSF Perinatal HIV Clinic and is Medical Director of HIVE, the Bay Area Perinatal AIDS Center at SF General.